他汀类药物防治动脉粥样硬化性心血管疾病:低密度脂蛋白胆固醇水平越低越好?

被引：3

作者：

李勇

机构：

[1] 复旦大学附属华山医院心脏科

来源：

上海医药 | 2009年 / 30卷 / 11期

关键词：

他汀类; 药物治疗; 相对危险; 心血管; 动脉粥样硬化; 心肌梗死; 降脂治疗; 动脉硬化; LDL; 非致死性; 阿托伐他汀; 普伐他汀; 强化降脂; 低密度脂蛋白胆固醇; 罗苏伐他汀; 终点事件; 辛伐他丁; 降血脂药; 辛伐他汀;

D O I：

暂无

中图分类号：

R543 [血管疾病];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：491 / 494

页数：4

共 5 条

[1]

The Issue of Statin Safety: Where do We Stand?[J] . Scott M. Grundy.Circulation . 2005 (23)

[2]

The Safety of Rosuvastatin as Used in Common Clinical Practice: A Postmarketing Analysis[J] . Alawi A. Alsheikh-Ali,Marietta S. Ambrose,Jeffrey T. Kuvin,Richard H. Karas.Circulation . 2005 (23)

[3] Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions [J].

Collins, R ;

Armitage, J ;

Parish, S ;

Sleight, P ;

Peto, R .

LANCET, 2004, 363 (9411) :757-767

[4]

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)

[5]

Rosuvastatin to pre-vent vascular events in men and women with elevated C-reactiveprotein .2 Ridker PM,Danielson E,Fonseca FA,et al. N Eng J Med . 2008

← 1 →